Abstract:Objective To explore the relationship between metabolic syndrome (MS) and vascular cognitive impairment (VCI) after ischemic stroke. Methods A total of 225 elderly ischemic stroke patients were selected from January 2015 to December 2016 in this retrospective study. All the patients were divided into study group (67 cases with MS) and control group (158 cases without MS). Admission blood lipids, blood pressure, blood glucose and β-amyloid protein of the two groups were collected, and the incidence of diabetes,hypertension, hyperlipidemia were compared between the two groups. Montreal cognitive function score (MoCA) was used to evaluate cognitive function to calculate the incidence of VCI before discharge. Logistic regression analysis was used to explore the independent influencing factors of VCI. Results There were significant differences in β-AP, HOMA-IR, HbAlc, LDL-C, HDL-C, BP and other indicators between the two groups in admission (P < 0.05). Study group presented significantly higher incidence on T2DM, hypertension,hyperlipidemia and multiple lesions than those in the control group (P < 0.05). The total MoCA score of the patients in the study group was significantly lower than that in the control group before discharge (P < 0.05),and VCI incidence rate in the study group was significantly higher than that in the control group (P < 0.05).Age, neural function defect score, multiple lesions, number of MS components were independent risk factors of VCI secondary to ischemic stroke (P < 0.05), and the more the number of MS syndromes was and the higher of the age and neurological deficit score were, the higher the incidence of risk of VCI was ( OR > 1). Conclusions The cognitive impairment secondary to ischemic stroke is more serious in patients with MS than without MS, and MS can be an independent predictor of VCI after ischemic stroke.